Back to Trades
Bazemore Robert B
DirectorCIK 0001620152
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 3
- Active
- 2025–2026
Bazemore Robert B, Director, has filed 4 SEC reports (2025–2026), spread across 3 companies, totaling $1.5M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Oct 16 | AKTX Akari Therapeutics Plc | Bazemore Robert B | Director | Grant | $140.4K |
| Jun 18 | ARDX ARDELYX, INC. | Bazemore Robert B | Director | Grant | $225.2K |
| May 26 | NUVB Nuvation Bio Inc. | Bazemore Robert B | Insider | Award | $591.1K |
| Dec 18 | AKTX Akari Therapeutics Plc | Bazemore Robert B | Director | Other | $60.1K |
4 filings